LayerRx Mapping ID
268
Slot System
Featured Buckets
Featured Buckets Admin

Controlling irritable bowel syndrome

Article Type
Changed
Mon, 01/14/2019 - 10:19
Display Headline
Controlling irritable bowel syndrome
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
237
Sections
Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
237
Page Number
237
Publications
Publications
Topics
Article Type
Display Headline
Controlling irritable bowel syndrome
Display Headline
Controlling irritable bowel syndrome
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

The challenge of irritable bowel syndrome: Creating an alliance between patient and physician

Article Type
Changed
Fri, 03/01/2019 - 08:22
Display Headline
The challenge of irritable bowel syndrome: Creating an alliance between patient and physician
Article PDF
Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology, Cleveland Clinic

Edy Soffer, MD
Head, Center for Gastrointestinal Motility Disorders, Department of Gastroenterology, Cleveland Clinic

Address: Edy Softer, MD, Department of Gastroenterology, S40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
224-225, 229-233, 236
Sections
Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology, Cleveland Clinic

Edy Soffer, MD
Head, Center for Gastrointestinal Motility Disorders, Department of Gastroenterology, Cleveland Clinic

Address: Edy Softer, MD, Department of Gastroenterology, S40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Bo Shen, MD
Department of Gastroenterology, Cleveland Clinic

Edy Soffer, MD
Head, Center for Gastrointestinal Motility Disorders, Department of Gastroenterology, Cleveland Clinic

Address: Edy Softer, MD, Department of Gastroenterology, S40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
224-225, 229-233, 236
Page Number
224-225, 229-233, 236
Publications
Publications
Topics
Article Type
Display Headline
The challenge of irritable bowel syndrome: Creating an alliance between patient and physician
Display Headline
The challenge of irritable bowel syndrome: Creating an alliance between patient and physician
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Phenylpropanolamine and stroke: The study, the FDA ruling, the implications

Article Type
Changed
Fri, 03/01/2019 - 08:18
Display Headline
Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
Article PDF
Author and Disclosure Information

Tracey L. Mersfelder, PharmD
College of Pharmacy, Ferris State University, Grand Rapids, Michigan

Address: Tracey L. Mersfelder, PharmD, 715 Xavier Hall, 220 Cherry Street SE, Grand Rapids, Ml 49503

Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
208-209, 213-219, 223
Sections
Author and Disclosure Information

Tracey L. Mersfelder, PharmD
College of Pharmacy, Ferris State University, Grand Rapids, Michigan

Address: Tracey L. Mersfelder, PharmD, 715 Xavier Hall, 220 Cherry Street SE, Grand Rapids, Ml 49503

Author and Disclosure Information

Tracey L. Mersfelder, PharmD
College of Pharmacy, Ferris State University, Grand Rapids, Michigan

Address: Tracey L. Mersfelder, PharmD, 715 Xavier Hall, 220 Cherry Street SE, Grand Rapids, Ml 49503

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
208-209, 213-219, 223
Page Number
208-209, 213-219, 223
Publications
Publications
Topics
Article Type
Display Headline
Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
Display Headline
Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Making the most of cholesterol-lowering margarines

Article Type
Changed
Fri, 03/01/2019 - 08:08
Display Headline
Making the most of cholesterol-lowering margarines
Article PDF
Author and Disclosure Information

Julie K. Avery, RD
Nutrition Projects Coordinator, Preventive Cardiology and Rehabilitation Program, Cleveland Clinic Heart Center

Address: Julie K. Avery, RD, Cardiac Rehabilitation, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
194-196
Sections
Author and Disclosure Information

Julie K. Avery, RD
Nutrition Projects Coordinator, Preventive Cardiology and Rehabilitation Program, Cleveland Clinic Heart Center

Address: Julie K. Avery, RD, Cardiac Rehabilitation, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

Author and Disclosure Information

Julie K. Avery, RD
Nutrition Projects Coordinator, Preventive Cardiology and Rehabilitation Program, Cleveland Clinic Heart Center

Address: Julie K. Avery, RD, Cardiac Rehabilitation, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
194-196
Page Number
194-196
Publications
Publications
Topics
Article Type
Display Headline
Making the most of cholesterol-lowering margarines
Display Headline
Making the most of cholesterol-lowering margarines
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?

Article Type
Changed
Mon, 01/14/2019 - 09:42
Display Headline
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
Article PDF
Author and Disclosure Information

Donald G. Vidt, MD
Department of Nephrology and Hypertension, Cleveland Clinic; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Address: Donald G. Vidt, MD, Department of Nephrology and Hypertension, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195;  [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
189-190
Sections
Author and Disclosure Information

Donald G. Vidt, MD
Department of Nephrology and Hypertension, Cleveland Clinic; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Address: Donald G. Vidt, MD, Department of Nephrology and Hypertension, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195;  [email protected]

Author and Disclosure Information

Donald G. Vidt, MD
Department of Nephrology and Hypertension, Cleveland Clinic; member, Sixth Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Address: Donald G. Vidt, MD, Department of Nephrology and Hypertension, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195;  [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
189-190
Page Number
189-190
Publications
Publications
Topics
Article Type
Display Headline
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
Display Headline
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

What are ‘tissue ACE inhibitors,’ and should they be used instead of other ACE inhibitors?

Article Type
Changed
Fri, 03/01/2019 - 08:00
Display Headline
What are ‘tissue ACE inhibitors,’ and should they be used instead of other ACE inhibitors?
Article PDF
Author and Disclosure Information

Gary S. Francis, MD
Director, Coronary Intensive Care Unit, Department of Cardiology, Cleveland Clinic

John P. Gassler, MD
Interventional Fellow in Cardiology, University of Rochester, Strong Memorial Hospital, Rochester, New York

Address: Gary S. Francis, MD, Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
185-186
Sections
Author and Disclosure Information

Gary S. Francis, MD
Director, Coronary Intensive Care Unit, Department of Cardiology, Cleveland Clinic

John P. Gassler, MD
Interventional Fellow in Cardiology, University of Rochester, Strong Memorial Hospital, Rochester, New York

Address: Gary S. Francis, MD, Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Gary S. Francis, MD
Director, Coronary Intensive Care Unit, Department of Cardiology, Cleveland Clinic

John P. Gassler, MD
Interventional Fellow in Cardiology, University of Rochester, Strong Memorial Hospital, Rochester, New York

Address: Gary S. Francis, MD, Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
185-186
Page Number
185-186
Publications
Publications
Topics
Article Type
Display Headline
What are ‘tissue ACE inhibitors,’ and should they be used instead of other ACE inhibitors?
Display Headline
What are ‘tissue ACE inhibitors,’ and should they be used instead of other ACE inhibitors?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Rare but serious adverse effects in commonly used drugs

Article Type
Changed
Mon, 01/14/2019 - 08:40
Display Headline
Rare but serious adverse effects in commonly used drugs
Article PDF
Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
179
Sections
Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
179
Page Number
179
Publications
Publications
Topics
Article Type
Display Headline
Rare but serious adverse effects in commonly used drugs
Display Headline
Rare but serious adverse effects in commonly used drugs
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Multiple sclerosis: The importance of early recognition and treatment

Article Type
Changed
Thu, 12/27/2018 - 12:14
Display Headline
Multiple sclerosis: The importance of early recognition and treatment
Article PDF
Author and Disclosure Information

Robert J. Fox, MD
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic

Jeffrey A. Cohen, MD
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic

Address: Robert J. Fox, MD, Mellen Center U-10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(2)
Publications
Topics
Page Number
157-171
Sections
Author and Disclosure Information

Robert J. Fox, MD
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic

Jeffrey A. Cohen, MD
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic

Address: Robert J. Fox, MD, Mellen Center U-10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Robert J. Fox, MD
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic

Jeffrey A. Cohen, MD
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic

Address: Robert J. Fox, MD, Mellen Center U-10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(2)
Issue
Cleveland Clinic Journal of Medicine - 68(2)
Page Number
157-171
Page Number
157-171
Publications
Publications
Topics
Article Type
Display Headline
Multiple sclerosis: The importance of early recognition and treatment
Display Headline
Multiple sclerosis: The importance of early recognition and treatment
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Strategies to prevent progression of renal disease

Article Type
Changed
Tue, 05/03/2022 - 16:11
Display Headline
Strategies to prevent progression of renal disease
Article PDF
Author and Disclosure Information

Phillip M. Hall, MD
Department of Nephrology, Cleveland Clinic

Address: Phillip M. Hall, MD, Department of Nephrology, A101, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(2)
Publications
Topics
Page Number
143-146, 149-151
Sections
Author and Disclosure Information

Phillip M. Hall, MD
Department of Nephrology, Cleveland Clinic

Address: Phillip M. Hall, MD, Department of Nephrology, A101, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Phillip M. Hall, MD
Department of Nephrology, Cleveland Clinic

Address: Phillip M. Hall, MD, Department of Nephrology, A101, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(2)
Issue
Cleveland Clinic Journal of Medicine - 68(2)
Page Number
143-146, 149-151
Page Number
143-146, 149-151
Publications
Publications
Topics
Article Type
Display Headline
Strategies to prevent progression of renal disease
Display Headline
Strategies to prevent progression of renal disease
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Aggressive treatment of dyslipidemia: A review of supporting evidence

Article Type
Changed
Tue, 05/03/2022 - 16:11
Display Headline
Aggressive treatment of dyslipidemia: A review of supporting evidence
Article PDF
Author and Disclosure Information

Evan A. Stein, MD, PhD
Medical Research Laboratories, Highland Heights, Kentucky

Address: Evan A. Stein, MD, PhD, 2 Tesseneer Drive, Highland Heights, KY 41076; [email protected]

Dr. Stein has received grant or research support from, has acted as a consultant for, and has been on the speakers' bureau of the Parke-Davis/Pfizer, Merck, Bayer, Novartis, Astra-Zeneca, and Schering-Plough corporations.

Issue
Cleveland Clinic Journal of Medicine - 68(2)
Publications
Topics
Page Number
130-131, 135-138, 141-142
Sections
Author and Disclosure Information

Evan A. Stein, MD, PhD
Medical Research Laboratories, Highland Heights, Kentucky

Address: Evan A. Stein, MD, PhD, 2 Tesseneer Drive, Highland Heights, KY 41076; [email protected]

Dr. Stein has received grant or research support from, has acted as a consultant for, and has been on the speakers' bureau of the Parke-Davis/Pfizer, Merck, Bayer, Novartis, Astra-Zeneca, and Schering-Plough corporations.

Author and Disclosure Information

Evan A. Stein, MD, PhD
Medical Research Laboratories, Highland Heights, Kentucky

Address: Evan A. Stein, MD, PhD, 2 Tesseneer Drive, Highland Heights, KY 41076; [email protected]

Dr. Stein has received grant or research support from, has acted as a consultant for, and has been on the speakers' bureau of the Parke-Davis/Pfizer, Merck, Bayer, Novartis, Astra-Zeneca, and Schering-Plough corporations.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(2)
Issue
Cleveland Clinic Journal of Medicine - 68(2)
Page Number
130-131, 135-138, 141-142
Page Number
130-131, 135-138, 141-142
Publications
Publications
Topics
Article Type
Display Headline
Aggressive treatment of dyslipidemia: A review of supporting evidence
Display Headline
Aggressive treatment of dyslipidemia: A review of supporting evidence
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media